Literature DB >> 29541815

Impact of the Right Ventricular Sokolow-Lyon Index in Children with Idiopathic Pulmonary Arterial Hypertension.

Johannes Krämer1, Felix Kreuzer1, Michael Kaestner1, Peter Bride1, Fabian von Scheidt1, Jannos Siaplaouras1, Heiner Latus2, Dietmar Schranz2, Christian Apitz3,4.   

Abstract

Right ventricular (RV) hypertrophy is regarded as the adaptation on chronic RV pressure load in pulmonary hypertension. As the RV Sokolow-Lyon index (RVSLI) is an electrocardiographic marker of RV hypertrophy, we hypothesized that RVSLI might be able to reflect RV pressure load. Therefore, the purpose of this study was to characterize the diagnostic impact of the RVSLI in children with idiopathic pulmonary arterial hypertension (IPAH) in order to assess disease severity and to evaluate its value for the prediction of worse outcome. Forty-two children (aged 3-17 years) with IPAH were included in this retrospective study. The follow-up after baseline examination was 59 ± 17 months. Receiver-operating characteristic (ROC) curves and Kaplan-Meier analysis were used to discriminate a cut-off value of RVSLI and to assess its predictive value regarding morbidity and mortality. In 12/42 patients (29%) severe cardiovascular events (defined as death, lung transplantation, or Potts shunt) were observed (time to event 20 ± 22 months). Patients with an event showed higher RVSLI values (3.6 ± 1.2 mV vs. 2.6 ± 1.6 mV; p < 0.05). ROC analysis discriminated an RVSLI of 2.1 as the best cut-off value (area under the ROC curve: 0.79, sensitivity: 0.91, specificity: 0.70, p < 0.05) to detect patients with high-risk PAH (mPAP/mSAP ratio > 0.75). Relative risk for a severe event with an index > 2.1 mV was 1.76 (95% CI 1.21-3.20). Relative risk for death with RVSLI > 2.1 mV was 2.01 (95% CI 1.61-4.80). Our study demonstrates a strong relationship between RVSLI and disease severity in children with IPAH. An RVSLI > 2.1 mV at the time of first diagnosis is a predictor for patients at risk for cardiac events. As an adjunct to the usual diagnostic assessment this parameter may therefore contribute to the initial prognostic estimation.

Entities:  

Keywords:  Adaptation; ECG; Hypertrophy; PAH; Pediatric cardiology; Right ventricle

Mesh:

Year:  2018        PMID: 29541815     DOI: 10.1007/s00246-018-1862-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  26 in total

1.  Electrocardiogram for the diagnosis of right ventricular hypertrophy and dilation in idiopathic pulmonary arterial hypertension.

Authors:  Grzegorz Kopeć; Anna Tyrka; Tomasz Miszalski-Jamka; Maciej Sobień; Marcin Waligóra; Mateusz Brózda; Piotr Podolec
Journal:  Circ J       Date:  2012-04-13       Impact factor: 2.993

Review 2.  Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis.

Authors:  Mark-Jan Ploegstra; Willemijn M H Zijlstra; Johannes M Douwes; Hans L Hillege; Rolf M F Berger
Journal:  Int J Cardiol       Date:  2015-01-27       Impact factor: 4.164

3.  Clinical features of paediatric pulmonary hypertension: a registry study.

Authors:  Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Journal:  Lancet       Date:  2012-01-11       Impact factor: 79.321

4.  Dispersion durations of P-wave and QT interval in children with congenital heart disease and pulmonary arterial hypertension.

Authors:  Fatih Sap; Zehra Karataş; Hakan Altin; Hayrullah Alp; Bülent Oran; Tamer Baysal; Sevim Karaarslan
Journal:  Pediatr Cardiol       Date:  2012-09-13       Impact factor: 1.655

5.  Electrical and mechanical dyssynchrony in pediatric pulmonary hypertension.

Authors:  Allison C Hill; Dawn M Maxey; David N Rosenthal; Stephanie L Siehr; Seth A Hollander; Jeffrey A Feinstein; Anne M Dubin
Journal:  J Heart Lung Transplant       Date:  2012-06-08       Impact factor: 10.247

6.  Heart rate variability predicts outcome in children with pulmonary arterial hypertension.

Authors:  Astrid E Lammers; Elizabeth Munnery; Alison A Hislop; Sheila G Haworth
Journal:  Int J Cardiol       Date:  2009-01-26       Impact factor: 4.164

7.  Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology.

Authors:  Roberto Badagliacca; Roberto Poscia; Beatrice Pezzuto; Martina Nocioni; Mario Mezzapesa; Marco Francone; Elisa Giannetta; Silvia Papa; Cristina Gambardella; Susanna Sciomer; Maurizio Volterrani; Francesco Fedele; Carmine Dario Vizza
Journal:  J Heart Lung Transplant       Date:  2014-11-08       Impact factor: 10.247

8.  Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.

Authors:  S G Haworth; A A Hislop
Journal:  Heart       Date:  2008-10-24       Impact factor: 5.994

9.  Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death.

Authors:  M A Gatzoulis; J A Till; J Somerville; A N Redington
Journal:  Circulation       Date:  1995-07-15       Impact factor: 29.690

Review 10.  Mechanisms of disease: pulmonary arterial hypertension.

Authors:  Ralph T Schermuly; Hossein A Ghofrani; Martin R Wilkins; Friedrich Grimminger
Journal:  Nat Rev Cardiol       Date:  2011-06-21       Impact factor: 32.419

View more
  1 in total

1.  ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.

Authors:  Tomasz Adam Michalski; Joanna Pszczola; Anna Lisowska; Malgorzata Knapp; Bozena Sobkowicz; Karol Kaminski; Katarzyna Ptaszynska-Kopczynska
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.